Abstract:OBJECTIVE:Methylmalonic aciduria is the most common disorder of organic acidurias in the mainland of China. It is also the one of treatable metabolic disorders. The clinical spectrum of the patients varies from severe neonatal-onset forms with neonatal brain injury and high mortality to milder forms with adult-onset. The clinical manifestations of neonates with methylmalonic aciduria are non-specific. Early diagnosis and adequate treatment contribute a lot to improving the prognosis of the patients. In this study, the abnormal clinical and laboratory findings in neonatal period of 160 Chinese patients with early-onset methylmalonic aciduria were investigated.METHOD:From 1996 to 2011, a total of 398 patients with methylmalonic aciduria were diagnosed in our hospital; 286 (71.9%) patients had early-onset before 1 year of age. Among 286 patients, 160 (55.9%) presented symptoms in neonatal period. Their urine organic acids were analyzed by gas chromatography-mass spectrometry. Blood amino acids and acylcarnitine profiles were determined by liquid chromatography tandem mass spectrometry. Serum and urine total homocysteine were measured using a fluorescence polarization immunoassay. In some patients, gene analysis was performed. Based on the disease types and general condition, individual dietary and medical interventions were started soon after diagnosis.RESULT:Out of the 160 patients, 131 (81.9%) had combined methylmalonic aciduria and homocysteinemia. Isolated methylmalonic aciduria was found in 29 cases (18.1%). The common presentations in neonatal period were feeding difficulty, seizures, lethargy and dyspnea. Megaloblastic anemia, liver dysfunction, hyperammonemia and metabolic acidosis were the frequent findings in the routine laboratory test. The most common initial clinical diagnosis was suspected hypoxic-ischemic encephalopathy. Even in 36 cases with abnormal family history, only 3 patients were admitted with suspected inborn errors of metabolism. Five cases (3.1%) were diagnosed by postmortem metabolic examination; 7 cases (4.4%) were detected by newborn screening. In 148 cases (92.5%), the diagnosis was much delayed to the age of one month to 8 years and 5 months (mean 13 months). Methylmalonic aciduria combined with homocysteinemia (MMACHC) gene analyses were performed in 31 cases with combined methylmalonic aciduria. CblC defect was confirmed. The patients with isolated methylmalonic aciduria were treated with protein-restricted diet, cobalamin and L-carnitine. The patients of methylmalonic aciduria combined with homocysteinemia were treated with cobalamin, L-carnitine, calcium folinate, betaine and common diet. Seven patients died without treatment. Clinical improvement was observed in 153 patients. Only 2 patients detected by newborn screening had normal mental and physical development. Mild to severe psychomotor retardation was observed in 151 cases.CONCLUSION:High mortality and disability rates were observed in the patients with early-onset methylmalonic aciduria. Combined methylmalonic aciduria and homocysteinemia is the common type of methylmalonic aciduria. The clinical manifestation in neonatal period of the patients with early-onset methylmalonic aciduria is complex. Feeding difficulty, seizures, lethargy and dyspnea are the common symptoms in neonatal period of the patients. Megaloblastic anemia, liver dysfunction, hyperammonemia and metabolic acidosis were the frequent laboratory findings.

Easily Misdiagnosed cblC Deficiency in Adolescents: the Clinical and Metabolic Studies

Late-onset Cblc Deficiency Around Puberty: a Retrospective Study of the Clinical Characteristics, Diagnosis, and Treatment

Long-term Follow-Up of Children with Carbamoyl Phosphate Synthase 1 Deficiency Detected in Newborn Screening.

The First Case of Cobalamin F Disorder in China: Report and Literature Review

Clinical, Biochemical, and Molecular Analysis of Combined Methylmalonic Acidemia and Hyperhomocysteinemia (cblc Type) in China

A case of multiple carboxylase deficiency presenting with skin lesions as the initial symptom induced by a novel mutation in the holocarboxylase synthetase gene

[Genetic Analysis of Newborns with Abnormal Metabolism of 3-Hydroxyisovalerylcarnitine].

Variable Phenotypes and Outcomes Associated with the MMACHC C.609g>a Homologous Mutation: Long Term Follow-Up in a Large Cohort of Cases

[Factors Affecting Phenotypes in the Patients with MMACHC Gene C.609g>a Homozygous Variant Cblc Type Methylmalonic Acidemia Combined with Homocysteinuria].

Combined Methylmalonic Aciduria and Homocystinuria Cblc Type of a Taiwanese Infant with C.609g>a and C.567dupT Mutations in the MMACHC Gene.

[Clinical features and follow-up study on 55 patients with adolescence-onset methylmalonic acidemia]

Case report: An asymptomatic mother with an inborn error of cobalamin metabolism (cblC) detected through high homocysteine levels during prenatal diagnosis

[A Chinese Boy with Methylmalonic Aciduria Cblb Type and a Novel Mutation in the MMAB Gene].

Prominent Renal Complications Associated with MMACHC Pathogenic Variant C.80a > G in Chinese Children with Cobalamin C Deficiency

Mutation spectrum of MMACHC in Chinese pediatric patients with cobalamin C disease: A case series and literature review.

Late-onset cobalamin C deficiency type in adult with cognitive and behavioral disturbances and significant cortical atrophy and cerebellar damage in the MRI: a case report

[Abnormal Findings During Newborn Period of 160 Patients with Early-Onset Methylmalonic Aciduria].

Phenotypic and genotypic analysis of children with methylmalonic academia: A single-center study in China and a recent literature review

Identification of Eight Novel Mutations and Transcript Analysis of Two Splicing Mutations in Chinese Newborns with MCC Deficiency.

Patients with Cobalamin G or J Defect Missed by the Current Newborn Screening Program: Diagnosis and Novel Mutations.

Peripheral Nervous System Involvement in Late-Onset Cobalamin C Disease?